A retrospective case note study of 93 women was performed in order to asses
s the effect of maternal factors on neonatal outcome in a group of women at
tending a specialist clinic for pregnant drug users. There were no signific
ant differences in outcome for chaotic drug users compared with non-chaotic
drug users, or for cocaine users compared with non-cocaine using drug user
s. Women who reduced their methadone dose during pregnancy delivered babies
of significantly higher birth weight than those whose methadone dose remai
ned the same or increased (median 3027 g, range 1780-3629 g vs 2645 g, rang
e 580-3720 g). Women who abused benzodiazepines during pregnancy produced b
abies of significantly lower birth weight than those women who did not use
benzodiazepines (median 2100 g, range 580-3520 g vs 2767 g, range 1530-3720
g).
Conclusion The results of this study give healthcare staff evidence to use
in encouraging drug-using women to avoid benzodiazepines during pregnancy a
nd to reduce their methadone dosage. The treatment received from a speciali
st clinic may mitigate against some of the other recognised effects of drug
use during pregnancy.